Ronald R Breaker
Henry Ford II Professor of Molecular, Cellular, and Developmental Biology; Investigator, Howard Hughes Medical Institute
Departments & OrganizationsMolecular, Cellular, and Developmental Biology
Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Biochemistry, Biophysics and Structural Biology: RNA Catalysis and Ribonucleoprotein Machines
Center for RNA Science and Medicine, Yale
Diabetes Endocrinology Research Center
Dr. Breaker is the Chair and Henry Ford II Professor of the Department of Molecular, Cellular and Developmental Biology at Yale University, is jointly appointed as a professor in the Department of Molecular Biophysics and Biochemistry, and is an Investigator with the Howard Hughes Medical Institute. His graduate studies with Dr. Peter Gilham at Purdue University focused on the synthesis of RNA and the catalytic properties of nucleic acids. As a postdoctoral researcher with Dr. Gerald Joyce at The Scripps Research Institute, Dr. Breaker pioneered a variety of in vitro evolution strategies to isolate novel RNA enzymes and was the first to discover catalytic DNAs or “deoxyribozymes” using this technology. Since establishing his laboratory at Yale in 1995, Dr. Breaker has continued to conduct research on the advanced functions of nucleic acids, including ribozyme reaction mechanisms, molecular switch technology, next-generation biosensors, and catalytic DNA engineering. Most recently, his laboratory has established the first proofs that metabolites are directly bound by messenger RNA elements called riboswitches. Dr. Breaker’s research findings have been published in more than 100 scientific papers, book chapters, and patent applications, and his research has been funded by grants from the NIH, NSF, DARPA, the Hereditary Disease Foundation, and from several biotechnology and pharmaceutical companies. He is the recipient of fellowships from the Arnold and Mabel Beckman Foundation, the David and Lucile Packard Foundation, and the Hellman Family Trust. In recognition of his research accomplishments at Yale, Dr. Breaker received the Arthur Greer Memorial Prize (1997), the Eli Lilly Award in Microbiology (2005) and the Molecular Biology Award from the U.S. National Academy of Sciences (2006). Dr. Breaker has cofounded two biotechnology companies and is a scientific advisor for industry and for various covernment agencies. He serves on the editorial board for the scientific journals RNA Biology, RNA, Interdisciplinary Reviews: RNA, and Chemistry & Biology.